AMERISAFE financials
$23.87+0.46%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $92.0M | $80.1M | $81.6M | $82.0M | $81.1M | $72.6M | $74.0M | $78.7M | $75.8M | $80.5M | $80.1M | $72.6M |
| Gross profit | $27.5M | $27.0M | $25.0M | $34.1M | $26.1M | $26.4M | $29.1M | $33.9M | $22.0M | $34.6M | $37.8M | $29.5M |
| Gross margin | 29.9% | 33.7% | 30.7% | 41.6% | 32.2% | 36.3% | 39.3% | 43.1% | 29.0% | 43.0% | 47.2% | 40.6% |
| Operating income | $18.3M | $10.2M | $12.7M | $17.5M | $17.5M | $11.2M | $16.8M | $17.8M | $13.7M | $20.7M | $23.9M | $12.3M |
| Net income | $14.6M | $8.1M | $10.4M | $13.8M | $14.0M | $8.9M | $13.2M | $14.3M | $11.0M | $16.9M | $19.2M | $10.0M |
| Net margin | 15.9% | 10.2% | 12.8% | 16.9% | 17.2% | 12.3% | 17.8% | 18.2% | 14.5% | 21.0% | 23.9% | 13.7% |
| Diluted EPS | $0.78 | $0.43 | $0.55 | $0.72 | $0.73 | $0.47 | $0.69 | $0.75 | $0.57 | $0.88 | $1.00 | $0.52 |
| EBITDA | $18.4M | $10.3M | $12.9M | $17.7M | $17.8M | $11.7M | $17.4M | $18.3M | $14.8M | $21.1M | $23.9M | $13.2M |
| Operating cash flow | $1.8M | -$2.7M | $10.6M | $10.7M | -$8.4M | -$1.8M | $10.8M | $8.4M | -$2.6M | $7.5M | $4.0M | $5.1M |
| Free cash flow | $1.8M | -$2.7M | $10.4M | $9.8M | -$9.5M | -$1.8M | $10.8M | $8.4M | -$2.6M | $6.8M | $3.9M | $4.6M |
| Diluted shares | 18.7M | 18.9M | 19.0M | 19.1M | 19.1M | 19.2M | 19.2M | 19.1M | 19.1M | 19.2M | 19.2M | 19.2M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $65.5M | $34.2M | $61.9M | $54.7M | $48.5M | $44.8M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total assets | $1.13B | $1.12B | $1.13B | $1.16B | $1.16B | $1.16B |
| Total liabilities | $877.3M | $876.4M | $878.9M | $890.2M | $889.5M | $895.9M |
| Shareholders' equity | $250.0M | $246.6M | $251.6M | $274.8M | $265.6M | $260.8M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology